Skip to main content

Benefits of Direct-Acting Antivirals for Hepatitis C.

Publication ,  Journal Article
Lok, AS; Chung, RT; Vargas, HE; Kim, AY; Naggie, S; Powderly, WG
Published in: Annals of internal medicine
December 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Annals of internal medicine

DOI

EISSN

1539-3704

ISSN

0003-4819

Publication Date

December 2017

Volume

167

Issue

11

Start / End Page

812 / 813

Related Subject Headings

  • Review Literature as Topic
  • Humans
  • Hepatitis C, Chronic
  • General & Internal Medicine
  • Evidence-Based Medicine
  • Clinical Trials as Topic
  • Antiviral Agents
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lok, A. S., Chung, R. T., Vargas, H. E., Kim, A. Y., Naggie, S., & Powderly, W. G. (2017). Benefits of Direct-Acting Antivirals for Hepatitis C. Annals of Internal Medicine, 167(11), 812–813. https://doi.org/10.7326/m17-1876
Lok, Anna S., Raymond T. Chung, Hugo E. Vargas, Arthur Y. Kim, Susanna Naggie, and William G. Powderly. “Benefits of Direct-Acting Antivirals for Hepatitis C.Annals of Internal Medicine 167, no. 11 (December 2017): 812–13. https://doi.org/10.7326/m17-1876.
Lok AS, Chung RT, Vargas HE, Kim AY, Naggie S, Powderly WG. Benefits of Direct-Acting Antivirals for Hepatitis C. Annals of internal medicine. 2017 Dec;167(11):812–3.
Lok, Anna S., et al. “Benefits of Direct-Acting Antivirals for Hepatitis C.Annals of Internal Medicine, vol. 167, no. 11, Dec. 2017, pp. 812–13. Epmc, doi:10.7326/m17-1876.
Lok AS, Chung RT, Vargas HE, Kim AY, Naggie S, Powderly WG. Benefits of Direct-Acting Antivirals for Hepatitis C. Annals of internal medicine. 2017 Dec;167(11):812–813.

Published In

Annals of internal medicine

DOI

EISSN

1539-3704

ISSN

0003-4819

Publication Date

December 2017

Volume

167

Issue

11

Start / End Page

812 / 813

Related Subject Headings

  • Review Literature as Topic
  • Humans
  • Hepatitis C, Chronic
  • General & Internal Medicine
  • Evidence-Based Medicine
  • Clinical Trials as Topic
  • Antiviral Agents
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences